xenin-25 and Diabetes-Mellitus--Type-1

xenin-25 has been researched along with Diabetes-Mellitus--Type-1* in 1 studies

Other Studies

1 other study(ies) available for xenin-25 and Diabetes-Mellitus--Type-1

Article	Year
Effects of long-acting GIP, xenin and oxyntomodulin peptide analogues on alpha-cell transdifferentiation in insulin-deficient diabetic Glu Peptides, 2020, Volume: 125 Enzyme-resistant long-acting forms of the gut-derived peptide hormones, glucose-dependent insulinotropic polypeptide (GIP), xenin and oxyntomodulin (Oxm) have been generated, and exert beneficial effects on diabetes control and pancreatic islet architecture. The current study has employed alpha-cell lineage tracing in Glu Topics: Animals; Bacterial Proteins; Cell Transdifferentiation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Gastric Inhibitory Polypeptide; Gastrointestinal Agents; Glucagon-Secreting Cells; Islets of Langerhans; Luminescent Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurotensin; Oxyntomodulin	2020

Article

Year

Effects of long-acting GIP, xenin and oxyntomodulin peptide analogues on alpha-cell transdifferentiation in insulin-deficient diabetic Glu

Peptides, 2020, Volume: 125

Enzyme-resistant long-acting forms of the gut-derived peptide hormones, glucose-dependent insulinotropic polypeptide (GIP), xenin and oxyntomodulin (Oxm) have been generated, and exert beneficial effects on diabetes control and pancreatic islet architecture. The current study has employed alpha-cell lineage tracing in Glu

Topics: Animals; Bacterial Proteins; Cell Transdifferentiation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Gastric Inhibitory Polypeptide; Gastrointestinal Agents; Glucagon-Secreting Cells; Islets of Langerhans; Luminescent Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurotensin; Oxyntomodulin

2020